QED Investigative Site — Houston, Texas

QED Investigative Site is a clinical research site located in Houston, Texas, United States 77030-4009.

Crixeo Health Trust Score: 44/100 (POOR). This profile has not yet been claimed by the site owner.

QED Investigative Site has participated in 1 clinical trials.

Therapeutic areas: Advanced Cholangiocarcinoma, FGFR2 Gene Mutation.

Sponsors: QED Therapeutics, a BridgeBio company.

Sponsor Feasibility Report

Trust Score: 44/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for QED Investigative Site?

QED Investigative Site has a Crixeo Trust Score of 44/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has QED Investigative Site conducted?

QED Investigative Site has 1 clinical trials on record. Their work covers Advanced Cholangiocarcinoma, FGFR2 Gene Mutation.

Is QED Investigative Site accredited by Crixeo Health?

QED Investigative Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about QED Investigative Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.